Table 1 Minimum required WHO indicator criteria for validation of EMTCT of HIV and syphilis, and additional criteria for hepatitis B
Indicators | Netherlands 2014 | Netherlands 2015 | Criterion met? | |
|---|---|---|---|---|
Shared indicators HIV and syphilis | ||||
ANC coverage (at least one visit) of ≥95% | 99.2%a | 99.7%a | Yes | |
HIV indicators | ||||
Coverage of pregnant women who know their HIV status of ≥95% | 99.2%a | 99.7%a | Yes | |
Antiretroviral (ARV) coverage of HIV positive pregnant women of ≥95% (women with suppressed viral load at delivery) | 96% (84%)b | 100% (97%)b | Yes | |
Case rate of new paediatric HIV infection due to mother-to-child transmission (MTCT) of HIV of ≤50 cases per 100,000 live births | 0.57b | 0.00b | Yes | |
MTCT rate of HIV of < 5% in breastfeeding population OR MTCT rate of < 2% in non-breastfeeding populations | 0.75%b | Yes | ||
Syphilis indicators | ||||
Coverage of syphilis testing of pregnant women of ≥95% | 99.2%a | 99.7%a | Yes | |
Treatment of syphilis-seropositive pregnant women ≥95% (% registered referred to care) | 72.6%a | 70.5%a | Unknown | |
Case rate of congenital syphilis ≤50 cases per 100,000 live births | 0.00c-1.14d | 0.00c-0.59d | Presumably | |
Hepatitis B indicators | ||||
Hepatitis B virus vaccination: childhood vaccine coverage (third dose coverage) ≥90% | 93.1%e | 92.2%e | Yes | |
Hepatitis B virus birth-dose vaccination coverage or other approach to prevent mother-to-child transmission ≥90% | Birth-dose vaccination | 99.4%e | 99.4%e | Yes |
HBIg admission at birth | 99.8%f | 99.8%a | ||
HBsAg prevalence among children ≤0.1% | 0.0%g | 0.0%g | Yes | |